Aadi Bioscience, Inc.

NasdaqCM:AADI 株式レポート

時価総額:US$56.7m

Aadi Bioscience 将来の成長

Future 基準チェック /26

Aadi Bioscienceは、56.1%と38.8%でそれぞれ年率56.1%で利益と収益が成長すると予測される一方、EPSはgrowで55.9%年率。

主要情報

56.1%

収益成長率

55.9%

EPS成長率

Biotechs 収益成長28.4%
収益成長率38.8%
将来の株主資本利益率n/a
アナリストカバレッジ

Low

最終更新日07 Nov 2024

今後の成長に関する最新情報

Recent updates

Lacklustre Performance Is Driving Aadi Bioscience, Inc.'s (NASDAQ:AADI) 27% Price Drop

Jul 03
Lacklustre Performance Is Driving Aadi Bioscience, Inc.'s (NASDAQ:AADI) 27% Price Drop

Will Aadi Bioscience (NASDAQ:AADI) Spend Its Cash Wisely?

Jul 02
Will Aadi Bioscience (NASDAQ:AADI) Spend Its Cash Wisely?

Analyst Forecasts Just Became More Bearish On Aadi Bioscience, Inc. (NASDAQ:AADI)

May 10
Analyst Forecasts Just Became More Bearish On Aadi Bioscience, Inc. (NASDAQ:AADI)

Improved Revenues Required Before Aadi Bioscience, Inc. (NASDAQ:AADI) Stock's 28% Jump Looks Justified

Mar 07
Improved Revenues Required Before Aadi Bioscience, Inc. (NASDAQ:AADI) Stock's 28% Jump Looks Justified

Here's Why We're Watching Aadi Bioscience's (NASDAQ:AADI) Cash Burn Situation

Feb 12
Here's Why We're Watching Aadi Bioscience's (NASDAQ:AADI) Cash Burn Situation

Why Investors Shouldn't Be Surprised By Aadi Bioscience, Inc.'s (NASDAQ:AADI) 48% Share Price Plunge

Dec 16
Why Investors Shouldn't Be Surprised By Aadi Bioscience, Inc.'s (NASDAQ:AADI) 48% Share Price Plunge

Analysts Have Lowered Expectations For Aadi Bioscience, Inc. (NASDAQ:AADI) After Its Latest Results

Nov 10
Analysts Have Lowered Expectations For Aadi Bioscience, Inc. (NASDAQ:AADI) After Its Latest Results

Is Aadi Bioscience (NASDAQ:AADI) In A Good Position To Deliver On Growth Plans?

Oct 03
Is Aadi Bioscience (NASDAQ:AADI) In A Good Position To Deliver On Growth Plans?

Here's Why We're Not Too Worried About Aadi Bioscience's (NASDAQ:AADI) Cash Burn Situation

Jun 28
Here's Why We're Not Too Worried About Aadi Bioscience's (NASDAQ:AADI) Cash Burn Situation

Is Aadi Bioscience (NASDAQ:AADI) In A Good Position To Deliver On Growth Plans?

Mar 04
Is Aadi Bioscience (NASDAQ:AADI) In A Good Position To Deliver On Growth Plans?

Aadi Bioscience highlights combination of KRAS inhibitors and nab-sirolimus for tumors

Oct 12

A Look At The Fair Value Of Aadi Bioscience, Inc. (NASDAQ:AADI)

Sep 28
A Look At The Fair Value Of Aadi Bioscience, Inc. (NASDAQ:AADI)

Aadi Bioscience: Taking mTOR Inhibition To The Next Level

Sep 21

Is Aadi Bioscience (NASDAQ:AADI) In A Good Position To Deliver On Growth Plans?

Jul 06
Is Aadi Bioscience (NASDAQ:AADI) In A Good Position To Deliver On Growth Plans?

Aadi Bioscience to enter Russell 2000 and Russell 3000 indexes

Jun 23

What You Need To Know About The Aadi Bioscience, Inc. (NASDAQ:AADI) Analyst Downgrade Today

Nov 27
What You Need To Know About The Aadi Bioscience, Inc. (NASDAQ:AADI) Analyst Downgrade Today

Aadi Bioscience: FDA Approval Of Fyarro Only The Beginning

Nov 25

業績と収益の成長予測

NasdaqCM:AADI - アナリストの将来予測と過去の財務データ ( )USD Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
12/31/202643-26-52N/A3
12/31/202528-29-56N/A4
12/31/202426-52-49N/A2
9/30/202425-62-56-54N/A
6/30/202424-65-54-50N/A
3/31/202424-69-61-58N/A
12/31/202324-66-64-60N/A
9/30/202323-63-65-61N/A
6/30/202322-62-60-58N/A
3/31/202319-62-53-52N/A
12/31/202215-61-50-50N/A
9/30/202211-63-51-51N/A
6/30/20227-136-60-60N/A
3/31/20223-119-52-52N/A
12/31/20211-111-22-22N/A
9/30/202114-87-13-13N/A
6/30/202115-211N/A
3/31/202115-622N/A
12/31/202015-4-13-13N/A
12/31/20191-13-8-8N/A

アナリストによる今後の成長予測

収入対貯蓄率: AADI今後 3 年間、利益が出ない状態が続くと予測されています。

収益対市場: AADI今後 3 年間、利益が出ない状態が続くと予測されています。

高成長収益: AADI今後 3 年間、利益が出ない状態が続くと予測されています。

収益対市場: AADIの収益 ( 38.8% ) US市場 ( 9% ) よりも速いペースで成長すると予測されています。

高い収益成長: AADIの収益 ( 38.8% ) 20%よりも速いペースで成長すると予測されています。


一株当たり利益成長率予想


将来の株主資本利益率

将来のROE: AADIの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です


成長企業の発掘